XML 45 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash Flows from Operating Activities:    
Net loss $ (467,847) $ (343,992)
Adjustments to reconcile net loss to net cash used in operating activities:    
Consulting expense 258,186 2,917
Loss on settlement of debt   74,075
Changes in operating assets and liabilities:    
Accounts receivable (583,333)  
Interest receivable   5,159
Prepaid expenses and deposits 218,658 (202,051)
Film costs 2,106,628 (2,535,359)
Accrued liabilities (45,424) 89,693
Deferred film revenue (1,445,073) 1,799,471
Interest payable 67,534 50,323
Other payable (55,000) 55,000
Net Cash Provided by (Used in) Operating Activities 54,328 (1,004,764)
Cash Flows from Investing Activities:    
Issuance of promissory note receivable   (350,000)
Collection of promissory note receivable   750,000
Loan receivable   (32,000)
Net Cash Provided by Investing Activities   368,000
Cash Flows from Financing Activities:    
Borrowing from related party 12,000  
Proceeds from issuance of promissory note payable   780,000
Proceeds from issuance of promissory note payable - related party 320,000 350,000
Payment of note payable (250,000) (500,000)
Payment of promissory note payable - related party (350,000) (200,000)
Proceeds from common stock subscribed   406,000
Retirement of common Stock   (20,000)
Net Cash Provided by (Used in) Financing Activities (268,000) 816,000
Net Increase in Cash and Cash Equivalents (213,672) 179,236
Cash and Cash Equivalents, beginning of period 270,826 91,590
Cash and Cash Equivalents, end of period 57,154 270,826
Supplemental Disclosure Information:    
Cash paid for interest   40,000
Cash paid for income taxes 0 0
Supplemental Non-cash Disclosure:    
Deferred consulting expense paid in restricted stock $ 225,000 140,000
Conversion of debt into common stock   $ 127,716